Brighthouse Financial (BHF) Q3 2026 earnings review
Brighthouse buyout misses its December deadline while core profit falls
Brighthouse Financial saw core earnings and regulatory capital slip while its pending buyout ran into state regulatory delays. Profit excluding one-offs fell 18% from a year ago to $213 million as annuity sales dropped 12% and claim costs rose. A one-time accounting gain from its annual insurance review lifted headline profit, but statutory reserves moved the other way and trimmed the insurer's capital buffer.
| Profit per share, excluding one-offs | $3.68 -19% from a year ago |
|---|---|
| Annuity sales | $2.41B -12% from a year ago |
| Estimated regulatory capital (RBC) ratio | 415%–435% 430%–450% last quarter |
| Aquarian buyout timeline ($70/share) | Delayed past the Dec 6, 2026 deadline |
⚖️ Verdict: 🔴 Bearish
The story got worse because the $70-per-share sale to Aquarian Capital will miss its extended December 6 deadline while the underlying balance sheet weakens. Insurance regulators in Delaware, New York and Massachusetts have still not cleared the deal after a year of review, forcing the two sides to negotiate a contract extension. One bright spot: savers bought $2.1 billion of flagship Shield retirement contracts, and higher private-fund returns lifted holding company cash to $1.0 billion.
The question now is whether Brighthouse and Aquarian sign a clean deadline extension or whether regulators demand capital concessions that put the deal at risk. If the delay is purely administrative, both sides will extend the contract and close in early 2027; if state regulators require more capital after the recent reserve drop, the buyout terms could face pressure. An amended merger filing before the December 6 deadline will tell.
🐂 Bull Case
Shield Annuity Demand Holds Up While Fixed Sales Collapse
Brighthouse Financial sells retirement and life insurance policies across the United States. Total annuity sales fell 11.6% from a year ago to $2.41 billion, "driven by lower fixed annuity sales, partially offset by strong sales of Shield Level Annuities," the company said. Shield Level Annuities are index-linked retirement contracts that give savers market gains up to a cap while absorbing a set portion of any market drop.
Savers kept buying Shield contracts even as traditional fixed products dried up. Shield sales rose 2.8% from a year ago to $2.11 billion, making up 87.4% of all annuity sales by our math. Over the same period, fixed deferred annuity sales fell 83.3% to $63 million, and fixed index annuity sales dropped 68.3% to $40 million because buyers favored equity-linked protection over plain fixed rates.
What to watch: fourth-quarter Shield sales and variable annuity withdrawals in the next financial supplement. Continued Shield growth above $2 billion a quarter would show that pending buyout delays have not stopped independent brokers from selling the flagship product.
Alternative Investments Lift Portfolio Yield and Holding Cash
Brighthouse invests the premiums customers pay into bonds, mortgages and private funds to earn spread income. Investment income excluding one-offs rose $71 million from last quarter to $1.31 billion, "driven by higher alternative investment income," the insurer said. That rebound pushed the portfolio yield excluding one-offs up 0.24 percentage points from the second quarter to 4.41%, matching the level from a year ago.
Liquid assets at the parent holding company also edged up to $1.0 billion from $900 million in the first two quarters of the year. Because the operating subsidiaries paid no dividends to the parent company during the first nine months of 2026, keeping $1.0 billion in parent cash gives the business a solid buffer to cover $38 million in quarterly debt interest and $26 million in preferred dividends.
What to watch: full-year statutory dividend disclosures in the fourth-quarter supplement. A transfer of cash from the insurance subsidiaries to the parent before year-end would prove that tighter regulatory capital rules have not trapped liquidity inside the operating units.
🐻 Bear Case
State Regulators Delay the Aquarian Buyout Past December
In November 2025, investment firm Aquarian Capital agreed to buy Brighthouse Financial for $70.00 per share in cash, or about $4.1 billion. Shareholders approved the deal in February, and only insurance regulators in Delaware, New York and Massachusetts still need to sign off. When the review ran past September 6, the contract automatically pushed the deadline to December 6, 2026, after which either side can walk away.
Now the insurer admits that "the necessary regulatory approvals are not expected to be received in time to complete the merger by the Outside Date." Brighthouse and Aquarian "currently are in discussions regarding amending the merger agreement to extend the Outside Date and remain committed to the merger," the company wrote. Still, the release warned there is no guarantee they will agree on a new date.
The delay matters because thirteen months have already passed since the deal announcement without state clearance. While the review drags on, merger restrictions limit how Brighthouse runs its business and prevent it from buying back shares or seeking other buyers. If state regulators demand extra capital commitments before approving the buyer, the talks to extend the December 6 contract deadline could stall.
What to watch: a formal SEC filing before December 6, 2026, announcing an amended merger agreement. A signed extension with a clear 2027 deadline would confirm Aquarian remains committed despite the state regulatory bottleneck.
Higher Interest Rates and New Rules Drain Statutory Capital
Insurance regulators judge financial strength using total adjusted capital, the statutory reserve buffer held inside insurance subsidiaries, and the risk-based capital (RBC) ratio. Brighthouse highlighted that its estimated RBC ratio of 415% to 435% remains "within our target range of 400% to 450% in normal market conditions." Yet that headline ratio stayed inside the band only because the Delaware reinsurance arm paid a $600 million special dividend into the main life subsidiary.
- Statutory combined total adjusted capital: $4.8 billion, down 11.1% from $5.4 billion a year ago
- Combined statutory net loss: $300 million in the third quarter and $3.08 billion over nine months
- Estimated RBC ratio middle of the range: 425%, down from 440% in the second quarter and 456% at year-end
Capital shrank because of "the effects from the significant rise in interest rates in the quarter" and "a reserve increase from the statutory annual actuarial review," the company said. Adopting the regulator's new Generator of Economic Scenarios (GOES) rules for variable and Shield annuities also raised required reserves. Drawing $600 million from the Delaware unit propped up the ratio once, but underlying statutory capital is eroding.
What to watch: year-end combined total adjusted capital and the exact fourth-quarter RBC ratio. A drop below 400% or another internal capital transfer would show that rate swings and the new regulatory framework are straining the balance sheet.
Core Profit Drops Across Every Operating Segment
Headline profit excluding market swings included a $314 million one-time boost from the annual actuarial review, which hides a broad drop in underlying earnings. Stripping out notable items, profit fell 18.4% from a year ago to $213 million, or $3.68 per share, down from $258 million in the second quarter. Revenue excluding market swings dipped 3.1% from a year ago to $2.10 billion as customer policy fees declined.
- Annuities profit excluding one-offs: $302 million, down 2.9% from a year ago and down 13.5% from last quarter by our math
- Life profit excluding one-offs: $24 million, down 17.2% from $29 million a year ago by our math
- Run-off loss excluding one-offs: $82 million, 28.1% worse than the $64 million loss a year ago by our math
In the core Annuities unit, results "reflect a lower income annuity underwriting margin and higher amortization of deferred acquisition costs," the insurer said. Deferred acquisition costs (DAC), the upfront sales commissions spread over a policy's life, rose 0.6 percentage points of segment revenue from a year ago to 10.4%, while policyholder benefits and claims rose 1.0 percentage point to 10.4%. Across the company, policy fees dropped 3.4 percentage points of adjusted revenue from last quarter to 23.7%, squeezing profit margins.
What to watch: fourth-quarter Annuities underwriting margin and policy fees. Another drop when no actuarial review cushions the bottom line would leave quarterly profit excluding one-offs near $200 million.
👓 Other Themes
Annual Actuarial Review Splits Accounting Profit From Regulatory Reserves
Every third quarter, Brighthouse updates its long-term insurance assumptions. This year's review added $278 million to standard net income and $314 million to adjusted earnings, mostly via a $248 million gain in the Run-off segment, which holds older policies no longer sold. However, the statutory review went the opposite way and forced the insurer to add regulatory reserves, illustrating how accounting gains do not create spendable capital.
💲 Other KPIs
Customer withdrawals exceeded new deposits by $2.53 billion, a larger net outflow than $2.42 billion last quarter and $2.29 billion a year ago. Gross deposits rose 4.0% from a year ago to $2.40 billion, but surrenders and benefit payouts climbed 7.3% to $4.93 billion, shrinking the total account balance to $129.72 billion.
Net asset value per share excluding accumulated other comprehensive income (AOCI) — unrealized bond losses caused by interest rate moves — rose 6.2% from a year ago and 3.4% from last quarter. Including those unrealized bond losses, standard book value per share fell 29.4% from a year ago to $57.59 as higher rates lowered bond prices.
Pre-tax overhead and functional department costs stayed unchanged from the second quarter at $204 million, down from $227 million in the first quarter. Starting in 2026, the insurer stopped counting Aquarian buyout legal and advisory bills inside corporate expenses; on that same basis, overhead rose $4 million, or 2.0%, from $200 million a year ago.
🔮 Guidance
Unchanged. The insurer continues to target a regulatory capital ratio between 400% and 450% in normal markets. This quarter's estimated reading of 415% to 435% sits inside that band, but the middle of the range dropped 15 percentage points from the prior two quarters and 31 percentage points from the 456% level at the end of 2025.
❓ Key Questions
What is delaying insurance regulators in the three remaining states?
Delaware, New York and Massachusetts have reviewed the Aquarian buyout for a full year and will miss the December 6 deadline. Investors need to know whether regulators are asking for extra capital guarantees or governance changes before signing off.
How much capacity remains in the Delaware reinsurance subsidiary?
Brighthouse used a $600 million extraordinary dividend from Brighthouse Reinsurance Company of Delaware to keep its main life unit's capital ratio inside the 400% to 450% target. The release does not state how much surplus remains in Delaware after that transfer.
How much did the new GOES framework add to reserves?
The company combined the impact of its routine statutory actuarial review and the new Generator of Economic Scenarios (GOES) rules into one bullet point. Separating the two would show the ongoing capital cost of writing new Shield annuities under the new rules.
How much has the pending merger cost outside corporate expenses?
Beginning in 2026, Brighthouse removed merger-related costs from its pre-tax corporate expense figure, but it does not break out the exact dollar amount of those excluded transaction bills in the third-quarter tables.